Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 10.54 CNY -1.95% Market Closed
Market Cap: 4.6B CNY
Have any thoughts about
Hunan Fangsheng Pharmaceutical Co Ltd?
Write Note

Hunan Fangsheng Pharmaceutical Co Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hunan Fangsheng Pharmaceutical Co Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Total Current Assets
ÂĄ1B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
16%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Current Assets
ÂĄ28.9B
CAGR 3-Years
19%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Current Assets
ÂĄ15.1B
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Current Assets
ÂĄ34.8B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
18%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Current Assets
ÂĄ36.4B
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
11%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Current Assets
ÂĄ775.8m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hunan Fangsheng Pharmaceutical Co Ltd
Glance View

Market Cap
4.6B CNY
Industry
Pharmaceuticals

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.

Intrinsic Value
15 CNY
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Hunan Fangsheng Pharmaceutical Co Ltd's Total Current Assets?
Total Current Assets
1B CNY

Based on the financial report for Sep 30, 2024, Hunan Fangsheng Pharmaceutical Co Ltd's Total Current Assets amounts to 1B CNY.

What is Hunan Fangsheng Pharmaceutical Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
16%

Over the last year, the Total Current Assets growth was -10%. The average annual Total Current Assets growth rates for Hunan Fangsheng Pharmaceutical Co Ltd have been 7% over the past three years , 8% over the past five years , and 16% over the past ten years .

Back to Top